ACT Brief: Patient Journey and Study Design, Decentralization's True Cost, and Europe's Pharma Competitiveness Crisis

In today's ACT Brief, we examine understanding the patient journey from end to end, whether decentralization reduces site burden or just shifts it, and why nine European drugmakers are sounding urgent alarms.